THREAT: Testing Harms Related to Exposure to Allergenic and Epithelial Toxins
Dr. Komarow and his team at the National Institutes of Health (NIH) are conducting a clinical research study to better understand how everyday environmental exposures may affect allergic and inflammatory responses in healthy adults. With allergic and inflammatory conditions increasing over time, this study aims to explore how common substances in air, food, and personal care products influence human health.
An Open-Label Study of Zemaira (Alpha 1-Trypsin Inhibitor) in Subjects with Eosinophilic Esophagitis
Research Study #001854-I to explore the effects of Zemaira® for individuals with eosinophilic esophagitis (EoE). This study aims to understand how people with EoE feel while taking Zemaira® and whether it provides any benefits. By joining this research, you'll have the opportunity to contribute to medical advancements that could improve care for those with EoE. Every patient plays a key role in shaping future treatments and expanding knowledge about this condition.
Phase 1 Study of Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays
To learn how malaria develops in people; how the body's immune system reacts to malaria; and how malaria spreads from people to mosquitoes.
NIH Tests Fecal Transplant in Chronic Granulomatous Disease-Associated Colitis
Researchers at NIH are testing a new therapy in patients diagnosed with colitis due to chronic granulomatous disease (CGD). The research aims to see if restoring the gut microbiome reduces inflammation in the colon.